	Putin names little known firm to run pharma company spun off from Germany's Stada - Reuters
	Stada reports rosy earnings as CEO tempers expectations around possible sale, IPO - Fierce Pharma
	Advent submits 3.6-billion-euro binding offer for Stada - FirstWord Pharma
	Stada Postpones IPO Due to Market Volatility - WSJ
	German healthcare boss says his business is better bet than Big Pharma - Financial Times
	STADA success driven by Specialty segment growth - The Pharma Letter
	Sandoz, STADA, and Samsung Bioepis Report Strong Earnings From Biosimilars - Center for Biosimilars
	Stada plans to launch IPO as soon as Wednesday, sources say - Reuters